keyword
MENU ▼
Read by QxMD icon Read
search

rheumatoid arthritis vaccine prevention

keyword
https://www.readbyqxmd.com/read/27878345/low-vaccination-rates-among-patients-with-rheumatoid-arthritis-in-a-german-outpatient-clinic
#1
Marco Krasselt, Jean-Philipp Ivanov, Christoph Baerwald, Olga Seifert
Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring infections due to two reasons: the disease itself and the immunosuppressive therapy. Vaccinations against preventable diseases are therefore of utmost importance for these group of patients. To estimate vaccination frequencies among patients with rheumatoid arthritis, we studied patients in a survey and calculated vaccination rates based on their vaccination documents. Patients have been recruited from our outpatient clinic during one of their routine visits...
November 22, 2016: Rheumatology International
https://www.readbyqxmd.com/read/27739111/estimating-the-size-of-the-u-s-population-at-risk-of-severe-adverse-events-from-replicating-smallpox-vaccine
#2
Ellen P Carlin, Nichole Giller, Rebecca Katz
OBJECTIVE: To quantify the population at risk of serious adverse reactions to replicating smallpox vaccine. DESIGN AND SAMPLE: Conditions known or suspected to carry risk were identified via Centers for Disease Control and Prevention planning documents, other federal publications, and peer-reviewed literature. Conditions identified were categorized as historically recognized risks or more recently recognized immunocompromised states that may pose risk. Major historical risk factors were as follows: eczema/atopic dermatitis, pregnancy, HIV, and primary immunodeficiency...
October 13, 2016: Public Health Nursing
https://www.readbyqxmd.com/read/27229685/antibody-response-to-pneumococcal-and-influenza-vaccination-in-patients-with-rheumatoid-arthritis-receiving-abatacept
#3
Rieke Alten, Clifton O Bingham, Stanley B Cohen, Jeffrey R Curtis, Sheila Kelly, Dennis Wong, Mark C Genovese
BACKGROUND: Patients with rheumatoid arthritis (RA), including those treated with biologics, are at increased risk of some vaccine-preventable infections. We evaluated the antibody response to standard 23-valent pneumococcal polysaccharide vaccine (PPSV23) and the 2011-2012 trivalent seasonal influenza vaccine in adults with RA receiving subcutaneous (SC) abatacept and background disease-modifying anti-rheumatic drugs (DMARDs). METHODS: Two multicenter, open-label sub-studies enrolled patients from the ACQUIRE (pneumococcal and influenza) and ATTUNE (pneumococcal) studies at any point during their SC abatacept treatment cycle following completion of ≥3 months' SC abatacept...
2016: BMC Musculoskeletal Disorders
https://www.readbyqxmd.com/read/27029237/comparing-guideline-based-care-quality-for-inflammatory-bowel-disease-and-rheumatoid-arthritis-patients-within-a-medical-home
#4
Freddy Caldera, Sumona Saha, Arnold Wald, David M Cooley, Ying-Qi Zhao, Zhanhai Li, Christie M Bartels
BACKGROUND: Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) patient populations face similar risks of chronic immunosuppression including corticosteroid use. We compared the receipt of preventive services between IBD and RA populations according to published quality metrics. METHODS: We defined a single-center cohort of patients with IBD or RA receiving specialty and primary care. Electronic health record abstraction assessed quality metrics, sociodemographics, comorbidity, and utilization...
June 2016: Expert Review of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/26653668/effect-of-abatacept-on-the-immunogenicity-of-23-valent-pneumococcal-polysaccharide-vaccination-ppsv23-in-rheumatoid-arthritis-patients
#5
RANDOMIZED CONTROLLED TRIAL
Kiyoshi Migita, Yukihiro Akeda, Manabu Akazawa, Shigeto Tohma, Fuminori Hirano, Haruko Ideguchi, Hideko Kozuru, Yuka Jiuchi, Ryutaro Matsumura, Eiichi Suematsu, Tomoya Miyamura, Shunsuke Mori, Takahiro Fukui, Yasumori Izumi, Nozomi Iwanaga, Hiroshi Tsutani, Kouichirou Saisyo, Takao Yamanaka, Shiro Ohshima, Naoya Mori, Akinori Matsumori, Koichiro Takahi, Shigeru Yoshizawa, Yojiro Kawabe, Yasuo Suenaga, Tetsuo Ozawa, Norikazu Hamada, Yasuhiro Komiya, Toshihiro Matsui, Hiroshi Furukawa, Kazunori Oishi
INTRODUCTION: Patients with rheumatoid arthritis (RA) treated with abatacept (ABT) are at increased risk for vaccine-preventable infections. The aim of the present study is to evaluate the humoral response to 23-valent pneumococcal polysaccharide (PPSV23) vaccination in RA patients receiving ABT. METHODS: The immunogenicity study was nested within a randomized, double-blind placebo-controlled study, designed to evaluate the efficacy of the PPSV23. PPSV23 was given to 111 RA patients, who were classified into three groups: RA control (n = 35), methotrexate (MTX) alone (n = 55), and ABT (n = 21)...
2015: Arthritis Research & Therapy
https://www.readbyqxmd.com/read/26440665/neutralizing-antibody-response-after-intramuscular-purified-vero-cell-rabies-vaccination-pvrv-in-iranian-patients-with-specific-medical-conditions
#6
Pooneh Rahimi, RouhAllah Vahabpour, Mohammad Reza Aghasadeghi, Syed Mehdi Sadat, Nader Howaizi, Ehsan Mostafavi, Ali Eslamifar, Vida Fallahian
OBJECTIVE: Post exposure prophylaxis using one of the WHO-approved vaccines is the method of choice for preventing rabies. Abnormal immune function in patients with some specific medical conditions, such as pregnancy, chronic hepatitis B virus infection, different types of cancers like lymphoma, diabetes I and II, corticosteroid consumption by patients with rheumatoid arthritis and lupus erythematosus, could impair the immunologic response to various vaccines. The immune response to rabies vaccination has never been examined in patients with any of these described medical conditions...
2015: PloS One
https://www.readbyqxmd.com/read/26271174/-serious-infection-due-to-biologicals-risk-only-mildly-elevated-in-patients-with-rheumatoid-arthritis
#7
Alfons A den Broeder, Henk J Schers
Biologicals are often thought to increase the risk of infection. A recent review shows that the risk of serious infection in patients with rheumatoid arthritis being treated with biologicals (standard dose) is only mildly elevated compared with those who are treated with conventional DMARDs only (odds ratio: 1.3). If biologicals are used at a lower dosage, e.g. tapering studies, the risk of serious infection does not seem to be increased. Alertness for infection in these patients, dose tapering and preventive measures such as vaccination, patient education and tuberculosis screening may potentially further reduce this serious side effect of biologicals...
2015: Nederlands Tijdschrift Voor Geneeskunde
https://www.readbyqxmd.com/read/26258277/bilateral-iritis-after-vaccine-for-bladder-cancer
#8
Alberto Parafita-Fernández, Manuel A Parafita
PURPOSE: Bacille Calmette-Guérin (BCG) is a vaccine that can be instilled into the urinary bladder as immunotherapy against superficial bladder cancer. Several case reports have implicated intravesical BCG in the development of uveitis. Patients treated with BCG therapy may present with systemic symptoms resembling reactive arthritis and, less frequently, have ocular adverse effects including bilateral panuveitis or chorioretinitis. In all but three previously reported cases of uveitis associated with BCG treatment, HLA-B27 has been positive...
October 2015: Optometry and Vision Science: Official Publication of the American Academy of Optometry
https://www.readbyqxmd.com/read/26117596/prevention-of-cardiovascular-disease-in-rheumatoid-arthritis
#9
REVIEW
I Hollan, P H Dessein, N Ronda, M C Wasko, E Svenungsson, S Agewall, J W Cohen-Tervaert, K Maki-Petaja, M Grundtvig, G A Karpouzas, P L Meroni
The increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) has been recognized for many years. However, although the characteristics of CVD and its burden resemble those in diabetes, the focus on cardiovascular (CV) prevention in RA has lagged behind, both in the clinical and research settings. Similar to diabetes, the clinical picture of CVD in RA may be atypical, even asymptomatic. Therefore, a proactive screening for subclinical CVD in RA is warranted. Because of the lack of clinical trials, the ideal CVD prevention (CVP) in RA has not yet been defined...
October 2015: Autoimmunity Reviews
https://www.readbyqxmd.com/read/26100340/reality-of-a-vaccine-in-the-prevention-and-treatment-of-atherosclerosis
#10
REVIEW
Victor García-González, Blanca Delgado-Coello, Armando Pérez-Torres, Jaime Mas-Oliva
Atherosclerosis together with multiple sclerosis, psoriasis and rheumatoid arthritis can be used as examples of chronic inflammatory diseases associated with multifactorial components that evolve over the years. Nevertheless, an important difference between these diseases relies on the fact that atherosclerosis develops from early ages where inflammation dominates the very beginning of the disease. This review highlights the inflammatory nature of atherosclerosis and the role the immune system plays in the process of atherogenesis...
July 2015: Archives of Medical Research
https://www.readbyqxmd.com/read/25962455/autoimmune-auto-inflammatory-syndrome-induced-by-adjuvants-asia-after-quadrivalent-human-papillomavirus-vaccination-in-colombians-a-call-for-personalised-medicine
#11
Juan-Manuel Anaya, Benjamin Reyes, Ana M Perdomo-Arciniegas, Bernardo Camacho-Rodríguez, Adriana Rojas-Villarraga
This was a case study in which 3 patients with autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination (HPV) were evaluated and described. All the patients were women. Diagnosis consisted of HLA-B27 enthesitis related arthritis, rheumatoid arthritis and systemic lupus erythematous, respectively. Our results highlight the risk of developing ASIA after HPV vaccination and may serve to increase the awareness of such a complication. Factors that are predictive of developing autoimmune diseases should be examined at the population level in order to establish preventive measures in at-risk individuals for whom healthcare should be personalized and participatory...
July 2015: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/25848463/risk-of-hepatitis-b-virus-reactivation-in-rheumatoid-arthritis-patients-undergoing-biologic-treatment-extending-perspective-from-old-to-newer-drugs
#12
REVIEW
Francesca De Nard, Monica Todoerti, Vittorio Grosso, Sara Monti, Silvia Breda, Silvia Rossi, Carlomaurizio Montecucco, Roberto Caporali
Hepatitis B virus (HBV) reactivation in rheumatoid arthritis (RA) patients undergoing biological therapy is not infrequent. This condition can occur in patients with chronic hepatitis B as well as in patients with resolved HBV infection. Current recommendations are mainly focused on prevention and management strategies of viral reactivation under tumor necrosis factor-α inhibitors or chimeric monoclonal antibody rituximab. In recent years, growing data concerning HBV reactivation in RA patients treated with newer biological drugs like tocilizumab and abatacept have cumulated...
March 27, 2015: World Journal of Hepatology
https://www.readbyqxmd.com/read/25766275/modulation-of-autoimmunity-and-atherosclerosis-common-targets-and-promising-translational-approaches-against-disease
#13
REVIEW
Daniel F J Ketelhuth, Göran K Hansson
Atherosclerosis is a chronic inflammatory disease of the arterial wall that is influenced by several risk factors, including hyperlipidemia and hypertension. Autoimmune diseases substantially increase the risk for cardiovascular disease (CVD). Although atherosclerotic CVD, such as myocardial and stroke, is much more prevalent than classical autoimmune conditions such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, these types of pathology have many similarities, raising the possibility that therapies against autoimmune disease can have beneficial effects on CVD...
2015: Circulation Journal: Official Journal of the Japanese Circulation Society
https://www.readbyqxmd.com/read/25734097/rates-of-pneumococcal-disease-in-adults-with-chronic-medical-conditions
#14
Kimberly M Shea, John Edelsberg, Derek Weycker, Raymond A Farkouh, David R Strutton, Stephen I Pelton
BACKGROUND: Although it is widely accepted that adults with immunocompromising conditions are at greatly increased risk of pneumococcal infection, the extent of risk among immunocompetent adults with chronic medical conditions is less certain, particularly in the current era of universal vaccination of children with pneumococcal conjugate vaccines. METHODS: We conducted a retrospective cohort study using data from 3 healthcare claims repositories (2006-2010) to compare rates of pneumococcal disease in immunocompetent adults with chronic medical conditions ("at-risk") and immunocompromised adults ("high-risk"), with rates in adults without these conditions ("healthy")...
March 2014: Open Forum Infectious Diseases
https://www.readbyqxmd.com/read/25627297/-vaccination-in-patients-from-bras%C3%A3-lia-cohort-with-early-rheumatoid-arthritis
#15
Luciana Feitosa Muniz, Carolina Rocha Silva, Thaís Ferreira Costa, Licia Maria Henrique da Mota
INTRODUCTION: Patients with a diagnosis of rheumatoid arthritis (RA) are at increased risk of infections. Vaccination is a recommended preventive measure. There are no studies evaluating the practice of vaccination in patients with early RA. OBJECTIVES: To evaluate the frequency of vaccination and the orientation (by the doctor) about vaccines among patients with early RA diagnosis. METHODS: Cross-sectional study including patients from the early RA Brasilia cohort...
September 2014: Revista Brasileira de Reumatologia
https://www.readbyqxmd.com/read/25229497/size-matters-nanotechnology-and-therapeutics-in-rheumatology-and-immunology
#16
REVIEW
Carl S Henderson, Andrew C Madison, Ankoor Shah
Nanotechnology, or the use of technology at the submicron scale, and its application to medicine (nanomedicine) draws from many ideas and technological advancements across myriad fields of materials technology and has improved biomedical understanding. Nanotechnology puts current materials science on the same physical scale as classic immune mediating substances, including viruses, moieties found on prokaryotic bacteria, and antigen presenting cells. Functionalized nanoparticles, fullerenes, liposomes, nanogels, and virus-like particles, are several examples of nanotechnology that are currently being applied to the treatment of oncologic and infectious diseases...
2014: Current Rheumatology Reviews
https://www.readbyqxmd.com/read/24720101/-recommendations-for-prevention-of-community-acquired-pneumonia-with-bacteremia-as-the-leading-form-of-invasive-pneumococcal-infections-in-the-population-of-people-over-50-years-of-age-and-risk-groups-above-19-years-of-age
#17
EDITORIAL
Piotr Albrecht, Adam Antczak, Waleria Hryniewicz, Anna Skoczyńska, Andrzej Radzikowski, Kornelia Kedziora-Kornatowska, Ewa Bernatowska, Tomasz Stompór, Tomasz Grodzicki, Ewa Gyrczuk, Jacek Imiela, Wiesław Jedrzejczak, Adam Windak
Invasive pneumococcal disease (IPD) is a main cause of mortality associated with pneumococcal infections. Although, IPD is regarding mainly small children and persons in the age > 65 years, the investigations showed that because of IPD exactly sick persons are burdened with the greatest mortality in the older age, rather than of children. The most frequent form of IPD is community acquired pneumonia (CAP) with the bacteremia. The presence of even a single additional risk factor is increasing the probability of the unfavorable descent of pneumococcal infection...
February 2014: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://www.readbyqxmd.com/read/24574221/a-single-functional-group-substitution-in-c5a-breaks-b-cell-and-t-cell-tolerance-and-protects-against-experimental-arthritis
#18
Christoph Kessel, Kutty S Nandakumar, Francis B Peters, Varun Gauba, Peter G Schultz, Rikard Holmdahl
OBJECTIVE: A deficiency in C5 protects against arthritis development. However, there is currently no approach successfully translating these findings into arthritis therapy, as by targeting the key component, C5a. The aim of this study was to develop a vaccination strategy targeting C5a as therapy for patients with rheumatoid arthritis. METHODS: An anti-C5a vaccine was generated by incorporating the unnatural amino acid p-nitrophenylalanine (4NPA) into selected sites in the murine C5a molecule...
March 2014: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/23837600/tuberculosis-current-state-of-knowledge-an-epilogue
#19
REVIEW
Chi Chiu Leung, Christoph Lange, Ying Zhang
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), has developed various mechanisms to survive and cause disease in the human host. Incomplete understanding of the complex microbe-host interactions has hindered the identification of suitable biomarkers to expedite the development of diagnostic tools, drugs and vaccines. The field effectiveness of directly observed therapy-short course has been compromised by the intrinsic limitations of sputum microscopy and suboptimal adherence to the long duration of treatment amid the HIV-TB syndemic and various socioeconomic constraints...
October 2013: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://www.readbyqxmd.com/read/23544146/decrease-in-blood-pressure-and-regression-of-cardiovascular-complications-by-angiotensin-ii-vaccine-in-mice
#20
Futoshi Nakagami, Hiroshi Koriyama, Hironori Nakagami, Mariana Kiomy Osako, Munehisa Shimamura, Mariko Kyutoku, Takashi Miyake, Tomohiro Katsuya, Hiromi Rakugi, Ryuichi Morishita
Vaccines have been recently developed to treat various diseases such as cancer, rheumatoid arthritis and Alzheimer's disease in addition to infectious diseases. However, before use in the clinical setting, vaccines targeting self-antigens must be demonstrated to be effective and safe, evoking an adequate humoral immune response from B cells while avoiding T cell activation in response to self. Although the vaccine targeting angiotensin II (Ang II) is efficient in rodents and humans, little is known regarding the immunological activation and safety of the vaccine...
2013: PloS One
keyword
keyword
84329
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"